The pathway to reimbursement is decisive for international market acceptance of U.S. medical devices. International Consultants and Team Members with global experience in American, European and Asian continents enable the planning of carefully, detailed and professionally designed strategies to determine best fit clinical environments and collaborators for maximum clinical utility and value.
Calculating Relevant Risks
The applications of new technologies in early international uses make it possible to review market opportunities, calculate relevant risks and costs for clinical and business development and address all outcome studies challenges for the pathway to certification and reimbursement.
Customized Int. Database
A clients customized database contains usually the clinical data packet articulating the medical necessity, a cost impact model and billing guide, the patient recruitment data; the protocol, the consent form and CRFs; the IRB or Ethics Committee submissions and approvals, the account level information about major relevant payers, and the account-specific tactics for driving positive coverage.
A Free Consultation
Please call us at +1(650) 336-8641 for an initial free telephone consultation.
Many can provide advice, but few can make it happen. Not only do we provide valuable advice in the commercialization process, we make these strategies become reality in engaging, preparing and training the early adopters of your technology..
The Right Partner For Europe.
European bench mark countries offer the opportunity to validate U.S. medtech technology, to complete opportunity assessments and to generate the comparative effectiveness data (CED), which is a potential condition of coverage by private payers and Centers for Medicare & Medicaid Services (CMS). European pilot trials are significantly less costly compared to U.S. trials, due to the reduced hospital, physician and investigator, diagnostic exam, and operating room expenses.
Haio Fauser is the Prinicipal Contractor at acroMIS. He is a start-up specialist for global strategies of medical technologies. Haio implements pilot trials for a non-CE marked device and he makes sure that his clients are hitting subsequent clinical and commercial milestones early.
Many European distributor and medical technology companies gain bandwidth and momentum with an evaluation of U.S. medtech in order to verify potential opportunities for mutual gain. Haio provides actual in-country support for European business development specialists with interest in cutting edge U.S. medical technology.
Haio Fauser ist der Firmengründer und Geschäftsführer von acroMIS LLC. Haio bietet Dienstleistungen für biomedizinischen Unternehmen an, die den kommerziellen Vertrieb, den Kontakt mit U.S. start-up Firmen oder die Anwendung durch erste U.S. Kunden suchen. Haio rekrutiert und arbeitet mit wichtigen U.S. Meinungsführern, und implementiert erste kommerzielle Ziele in den USA. Haio arbeitet als Auftragnehmer in langfristigen Projekten oder erfüllt einzelne Aufgaben.
acroMIS International Commercialization
Pick up the phone (1 650 336-8641) or email Haio (info@acroMIS.com), get your initial questions answered and see if you’d like to work with him. Contact Haio and he’ll get in touch with you to set up a time for an initial introduction and a phone call.